Purple Biotech Ltd.
PPBT
Last
$1.33
Day
-7.6%
1y
-76.7%
5y
-99.8%
52w
-89.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
1.53
EMA 50
1.63
EMA 200
4.98
20d high
-21.3%
5y high
-99.8%
5y range
0th
Positions held
Your positionsPPBT isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-30
Hold
avoid
Signal
Strong Sell
Target
$1.63
Stop
$1.28
Stop distance
3.8%
Target vs last
+22.6%
Fundamentals
| Market cap | $2.34M | Enterprise value | -$4.47M | Trailing P/E | — | Forward P/E | -1.43 |
| PEG | — | Price / book | 0.12 | Beta | -0.55 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -111.1% | ROA | -20.3% | Debt / equity | 0.01 |
| Current ratio | 3.70 | Free cash flow | -$4.90M | Analyst recommendation | none | Mean target | $17.00 |
| 52w high | $14.10 | 52w low | $1.16 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | $0.4M | -$0.1M | -$23.5M | -$1.3M | -$1.1M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$1.3M | -$2.3M | -$3.0M | -$1.4M | -$1.2M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$26.4M | -$7.2M | -$19.9M | -$21.7M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$7.0M | -$10.8M | -$22.3M | -$22.6M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsPPBT · daily-1.4% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin